CSL Limited (CMXHF)
OTCMKTS · Delayed Price · Currency is USD
121.49
+6.98 (6.10%)
Oct 31, 2025, 4:00 PM EDT
CSL Limited Market Cap
CSL Limited has a market cap or net worth of $56.4 billion as of October 31, 2025. Its market cap has decreased by -42.27% in one year.
Market Cap
56.40B
Enterprise Value
67.78B
Revenue
15.56B
Ranking
n/a
PE Ratio
18.79
Stock Price
$121.49
Market Cap Chart
Since June 2, 1994, CSL Limited's market cap has increased from 230.16M to 56.40B, an increase of 24,404.17%. That is a compound annual growth rate of 19.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 56.40B | -33.16% |
| Dec 31, 2024 | 84.38B | -10.61% |
| Dec 29, 2023 | 94.40B | 0.09% |
| Dec 30, 2022 | 94.31B | -6.81% |
| Dec 31, 2021 | 101.20B | 1.81% |
| Dec 31, 2020 | 99.40B | 13.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 660.18M |
| Glass House Brands | 563.78M |
| Northwest Biotherapeutics | 377.06M |
| Silence Therapeutics | 338.20M |
| Nika Pharmaceuticals | 311.89M |
| American Oncology Network | 302.09M |
| CytoDyn | 297.30M |